David B. Roberts - 03 Nov 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
03 Nov 2021
Net transactions value
-$753,917
Form type
4
Filing time
04 Nov 2021, 16:46:18 UTC
Previous filing
13 Sep 2021
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $11,476 +1,004 +18% $11.43* 6,527 03 Nov 2021 Direct F1
transaction LMAT Common Stock Options Exercise $264,344 +18,708 +287% $14.13* 25,235 03 Nov 2021 Direct F1
transaction LMAT Common Stock Sale $1,029,737 -19,712 -78% $52.24 5,523 03 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,004 -100% $0.000000* 0 03 Nov 2021 Common Stock 1,004 $11.43 Direct F3
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -18,708 -73% $0.000000 7,079 03 Nov 2021 Common Stock 18,708 $14.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $51.78 to $53.50. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 This option is fully vested and exercisable.